Multiple studies have show the drug is not effective at treating COVID-19, and in some cases can even cause heart problems.
James received the award for her contributions to understanding systemic autoimmune diseases such as lupus and rheumatoid arthritis.
The findings will allow for more targeted treatment approaches.
Berkley is board certified in neurology and sees patients in OMRF’s Multiple Sclerosis Center of Excellence.
The findings will help push clinicians closer to personalized medicine for lupus sufferers.
The award-winning Multiple Sclerosis Center of Excellence at OMRF is one of the preeminent MS research and treatment centers in the world.